Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Cocrystal Pharma, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 24 | 22 | −2 |
| Shares | 748.8K | 686.6K | −62.3K (−8.3%) |
| Value | $1.06M | $1.02M | −$41.1K (−3.9%) |
New holders (1)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 215 | $321 | 0.00% |
Sold out (3)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Neuberger Berman Group LLC | 59,271 | $84.2K |
| Citadel Advisors LLC | 10,034 | $14.2K |
| JPMorgan Chase & Co | 104 | $148 |